Rupture of a coronary artery aneurysm in Kawasaki disease: A rare case and review of the literature for the past 15 years  by Miyamoto, Takashi et al.
CASE REPORTSRupture of a coronary artery aneurysm in Kawasaki disease: A rare
case and review of the literature for the past 15 yearsTakashi Miyamoto, MD, PhD,a Kentaro Ikeda, MD,b Youichirou Ishii, MD, PhD,b and
Tomio Kobayashi, MD, PhD,b Gunma, JapanWe describe the rare case of a 3-month-old boy who had a
ruptured coronary artery aneurysm (CAA) in the right
coronary artery (RCA) combined with multiple CAAs in
the left circumflex and left anterior descending coronary
arteries. We also present a statistical analysis of all the
ruptured CAAs previously reported and review the litera-
ture of the past 15 years, focusing on the location, etiology,
diagnosis, management, and prognosis of giant CAAs.
CLINICAL SUMMARY
A 3-month-old Japanese boy was admitted to a neighbor-
hood hospital with reported fever 2 days in duration and
neck pain. He was treated for Kawasaki disease with intra-
venous immunoglobulin (IVIG; 2 g/kg) on days 5 and 8 ofFIGURE 1. Preoperative echocardiographic images. Images to right demonstra
Right coronary artery; LV, left ventricle; LA, left atrium; LCA, left circumflex c
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The Journal of Thoracic and Caillness and with prednisolone sodiummetazoate (INN pred-
nisolone; 2 mg/kg/d). He was transferred to our hospital for
further management. At admission, the patient’s abnormal
laboratory findings included a white blood cell count of
15,600 cells/mm3, a neutrophil percentage of 71%, a
platelet count of 27,000 cells/mm3, an aspartate amino-
transferase level of 161 IU/mL, a sodium level of 136
mmol/L, a C-reactive protein level of 11.1 mg/dL, and
hypoalbuminemia. Despite the treatment, the RCA aneu-
rysm enlarged progressively, reaching 14.2 mm in maximal
diameter by hospital day 23 of the illness, as shown by echo-
cardiography (Figure 1). At 2:00 AM on hospital day 24, the
patient suddenly lost consciousness, bradycardia devel-
oped, and the radial arterial pulse was not palpable. Despite
immediate cardiopulmonary resuscitation, the heart was not
beating and did not begin to beat even with open heart mas-
sage. After median sternotomy and pericardiotomy, the
RCA aneurysm rupture was confirmed. We attempted to
suture the ruptured coronary arterial wall, but it was too
fragile to suture. The heart did not regain spontaneous con-
tractions, even with extracorporeal membrane oxygenation
support for 5 days, and the patient died. Pathologic studies
revealed thickened aneurysmal wall with the presence of
the inflammatory.te markedly enlarged vessels (arrows) and pericardial effusion (PE). RCA,
oronary artery; Ao, aorta; F, diameter.
rdiovascular Surgery c Volume 147, Number 6 e67
TABLE 1. Summary of medical course of the ruptured coronary artery aneurysm
Study Study design Age Sex
Fever onset to
presentation (d)
Fever onset to
treatment (d) IVIG (mg/kg) Steroid
Fever onset
to rupture (d) Surgical procedure Outcome
Rowley, 1997, US Case report
(autopsy)
10 y Boy — — 2000 for 1 d  13 None Died
Case report
(autopsy)
22 mo Girl — — None  Unknown None Died
Koutlas, 1997, US Case report 3 y Boy — 14 2000 for 1 d  16 CABG, then PCPS,
then transplant
(POD 4)
Survived
Suzuki, 1999, Japan Case report
(autopsy)
4 y Girl 4 6 400 for 5 d þ 22 None Died
Maresi, 2001, Italy Case report
(autopsy)
2 mo Boy — — —  7 None Died
Vanlieferinghen,
2002, France
Case report
(autopsy)
6 mo Girl 7 — —  14 None Died
Donna, 2003, US Case report
(autopsy)
11 mo Boy 4 — —  16 None Died
Mok, 2003, China Case report 5 y Boy — 9 400 for 3 d  29 Pericardial window
at bedside, then
emergency CABG
with SVG
Survived
Wilson, 2004,
New Zealand
Case series
(autopsy)
2 mo Girl 2 3 þ (no details)  3 None Died
Imai, 2006, Japan Case series
(autopsy)
5 y Boy 2 3 þ (no details)  13 None Died
Miyamoto, 2013,
Japan
Case series
(autopsy)
3 mo Boy 2 4 2000 for 2 d þ 24 Pericardial window,
repair of raptured
CAAwith direct
closure.
Died
None of the reports listed cyclosporine use. IVIG, Intravenous immunoglobulin; CABG, coronary artery bypass grafting; PCPS, percutaneous cardiopulmonary support; POD,
postoperative day; SVG, saphenous vein graft; CAA, coronary artery aneurysm.
Case ReportsDISCUSSION
Rupture of a coronary aneurysm can occur within the first
few months after Kawasaki disease, but it is an exceedingly
rare occurrence. As of our last search date (September, 1
2013), a total of 9 other studies incorporating 10 patients
have described variations in the ruptured CAA since in
1997 (Tables 1 and 2). Among these, the aneurysms
became apparent within 1 to 2 weeks after the onset of
fever, rather than the usual course of 2 to 3 weeks.
Leukocytosis was found to be typical during the acute
stage of Kawasaki disease, with a predominance of
immature and mature granulocytes. Approximately 50%
of patients had reported white blood cell counts exceeding
10,000 cells/mm3. Acute-phase reactants, such as C-reac-
tive protein, were rapidly elevated within 2 weeks in 3 cases.
On the basis of histologic investigation of 37 autopsy cases,
Amano and colleagues1 classified arterial lesions into the
following 6 types according to the morphogenesis of arter-
itis: (1) endothelial degeneration and increased vascular
permeability, (2) edema and degeneration of media, (3)
necrotizing panarteritis, (4) granulation formation, (5) scar
formation, and (6) aneurysm formation. In our case of a
ruptured CAA, the wall of the aneurysm showed various
changes according to the duration of the disease. Efficacy
of IVIG and steroid (prednisolone at 2 mg/kg/d) therapy
has been reported in the treatment of severe Kawasakie68 The Journal of Thoracic and Cardiovascular Surgdisease. Patients should be treatedwith 2-g/kg IVIG in a sin-
gle infusion accompanied by aspirin.2 This therapy should
be started within the first 10 days of illness, as manifested
by elevated C-reactive protein. About 20% of patients
with Kawasaki disease do not have relief from fever with
the initial IVIG plus aspirin therapy3; however, the effects
of steroids on coronary artery abnormalities are still un-
known. An immunologic study has shown that hypercytoki-
nemia is observed in patients withKawasaki disease and that
cytokines are elevated in the acute phase of Kawasaki dis-
ease. It has been reported that inflammatory cytokines are
elevated in the acute phase of Kawasaki disease, and IVIG
and prednisolone rapidly ameliorate symptoms by reducing
cytokine levels. Inflammatory cytokines may mediate endo-
thelial damage and lead to coronary artery abnormalities.4,5
According to a previous study, however, some patients who
died of ruptured CAAwere treated with IVIG and steroids,
and most patient had progressive enlarging coronary
aneurysms larger than 10mm in diameter.5We think that pa-
tients with enlarged coronary aneurysms should be moni-
tored closely, and optimal surgical timing is within 1
month after the onset of the fever. Especially in cases with
giant aneurysm larger than 10 mm in diameter with rapid
progressive enlargement, despite intensive care, control of
blood pressure, and heart rate with b-blockers or calcium-
channel antagonists under general anesthesia, we shouldery c June 2014
TABLE 2. Summary of laboratory and cardiac findings of the ruptured coronary artery aneurysm
Study
Hb
(g/dL)
WBCs
(3103/mm3)
Platelets
(3103/mm3)
AST
(IU/L)
ALT
(IU/L)
CRP
(mg/dL) Echocardiogram
Ruptured
position Pathology
Rowley, 1997, US — — — — — — — — Inflammatory cells present in intima,
media, and adventitia of vessels;
IgA-producing cells present in all
3 layers
— — — — — — — — Inflammatory cells present in intima,
media, and adventitia of vessels;
IgA-producing cells present in all
3 layers
Koutlas, 1997, US 9.0 20 835 — — — Day 15, LMCA 15 mm, RCA 5 mm LMCA —
Suzuki, 1999, Japan 10.0 11.3 22 184 181 21.0 Day 6, LMCA 4 mm, RCA 3.3 mm;
day 15, LMCA 5 mm, RCA, 4
mm; day 22, giant aneurysm,
LMCA 15 mm, RCA 10 mm
LMCA (0.7-3 cm
from ostium)
Proliferation of fibroblasts and
myofibroblasts; inflammatory
infiltrates of lymphocytes and
plasma cells
Maresi, 2001, Italy — 27.59 895 — — — — LMCA (1 cm
from ostium)
At site of rupture, inflamed wall
epicardium; similar inflammation
in adventitia of remaining
coronary vessels
Vanlieferinghen,
2002, France
— 11.7 — — — — — LMCA Autopsy showed cardiac tamponade
caused by important ruptured
aneurysm of LCA
Donna, 2003, US — — — — — — — Proximal LAD Massive vessel wall destruction
characterized by loss of elastic
and muscular layers due to dense
lymphoplasmacytic infiltrate
Mok, 2003, China — — 111 — — — Day 6, LMCA 4.7 mm, RCA 18.6
mm; day 28, RCA 30 mm
Proximal RCA Not listed
Wilson, 2004,
New Zealand
— — — — — — — Proximal LAD Severe segmental necrotizing
arteritis of all coronary arteries;
mild to moderate fibrous intimal
proliferation associated focally
with organizing thrombus; focal
fibrinoid necrosis
Imai, 2006, Japan — 29.4 — — — 16.6 Day 7, LAD 8.1 mm; day 12, LAD
18 mm
Proximal LAD Inflammatory cell infiltration in
proximal or distal portion of
aneurysm in both right and left
coronary arteries, more prominent
in intima and adventitia than
media; fibrocellular intimal
thickening, rich in cells including
smooth muscle cells, covering
media
Miyamoto, 2013,
Japan
7.2 15.6 27 161 120 11.1 Day 13, RCA 5.0 mm, LCA 3.1 mm;
day 23, RCA 14.2 mm
Proximal RCA Internal elastic membrane of
coronary artery wall disappeared,
leading to rupture and extending
artery wall under influence of
blood pressure
Hb, Hemoglobin; WBCs, white blood cells; AST, aspartate aminotransferase; ALT, alanine aminotransferase; CRP, C-reactive protein; LMCA, left main coronary artery; RCA,
right coronary artery; LAD, left anterior descending coronary artery; LCA, left circumflex coronary artery; —, not listed in thesis.
Case Reportssuspect the possibility of the rupture. The patient should un-
dergo coronary artery bypass grafting as soon as possible.
Early intervention may offer the only chance for survival.
We thank Robert E. Brandt, founder, CEO, and CME of MedEd
Japan, for editing the manuscript.
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